2480.HK
LUZHU BIOTECH-B
HK$12.50
-3.85%
2026-06-10
About LUZHU BIOTECH-B
Beijing Luzhu Biotechnology Co., Ltd., a biotechnology company, develops human vaccines and therapeutic biologics to prevent and control infectious diseases, and to treat cancer and autoimmune diseases in Mainland China. The company is developing LZ901, a recombinant herpes zoster vaccine for which a biologics license application (BLA) has been submitted; K3, a recombinant human anti-tumor necrosis factor-alpha monoclonal antibody injection that has completed a Phase 1 clinical trial for the treatment of autoimmune diseases, such as rheumatoid arthritis, ankylosing spondylitis, and plaque psoriasis; and K193, a bispecific antibody injection in a Phase 1 clinical trial for the treatment of B cell leukemia and lymphoma. Its preclinical-stage product candidates comprise a recombinant varicella vaccine for the prevention of varicella in children; a recombinant syncytial virus (RSV) vaccine for RSV-induced lower respiratory tract disease; a recombinant HSV-1 vaccine that targets oral herpes or cold sores; a recombinant HSV-2 vaccine that targets genital herpes; K333, a bispecific antibody injection product for the treatment of myeloid leukemia; and K1932, a bispecific antibody to treat b cell lymphoma. In addition, the company offers immunoreagents, such as Group A meningococcal polysaccharide IgG, Group C meningococcal polysaccharide IgG, Group Y meningococcal polysaccharide IgG, Group W135 meningococcal polysaccharide IgG, and Haemophilus influenzae Type B polysaccharide IgG antibody detection kits; varicella-zoster virus antibody ELISA testing kits; and varicella-zoster virus antigen slides. Beijing Luzhu Biotechnology Co., Ltd. was incorporated in 2001 and is headquartered in Beijing, China.
Key Fundamentals
Forward P/E
11.31
EPS (TTM)
HK$-0.87
ROE
-19.9%
Profit Margin
0.0%
Debt/Equity
41.36
Price/Book
3.51
Beta
-0.73
Market Cap
HK$2.68B
Avg Volume (10D)
1K
Recent Breakout Signals
No recent breakout signals detected for 2480.HK.
Recent Price Range (60 Days)
60D High
HK$25.70
60D Low
HK$12.50
Avg Volume
12K
Latest Close
HK$12.50
Get breakout alerts for 2480.HK
Sign up for Breakout Scanner to receive daily notifications when 2480.HK triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial.
LUZHU BIOTECH-B (2480.HK) is listed on the Hong Kong Exchanges (HKEX). Breakout Scanner monitors 2480.HK daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. 2480.HK operates in the Healthcare sector within the Biotechnology industry. Data is provided for informational purposes only and does not constitute financial advice.